US Stock MarketDetailed Quotes

MDNAF Medicenna Therapeutics

Watchlist
  • 1.130
  • 0.0000.00%
15min DelayTrading Dec 30 16:00 ET
88.32MMarket Cap-4.26P/E (TTM)

About Medicenna Therapeutics Company

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.

Company Profile

SymbolMDNAF
Company NameMedicenna Therapeutics
Founded2015
CEODr. Fahar Merchant,PhD
MarketPink Market
Employees19
Fiscal Year Ends03-31
Address2 Bloor Street West,7th floor
CityToronto
ProvinceOntario
CountryCanada
Zip CodeM4W 3E2
Phone1-416-648-5555
Websitehttp://www.medicenna.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Fahar Merchant,PhD
  • President, Chief Executive Officer and Chairman of the Board
  • 877.19K
  • David Hyman
  • Chief Financial Officer
  • --
  • Rosemina Merchant
  • Chief Development Officer
  • 613.71K
  • Dr. John H. Sampson, M.B.A.,M.D.,PhD
  • Independent Director
  • 111.83K
  • Albert Beraldo, C.A.,C.P.A.
  • Lead Independent Director
  • 142.95K
  • Dr. John Geltosky, PhD
  • Independent Director
  • 117.45K
  • Karen A. Dawes, M.A.
  • Independent Director
  • 123.70K
  • Karim Lalji
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data